2003
Established Unibest Industrial, starting with chemical trading to lay the foundation for the supply chain.
Company
About Unibest
Founded in 2003. A pharmaceutical partner organised around supply programs, licensing and market access — with teams in Ningbo, Paris, New York and Auckland.
United, We Can Be the Best!
Established in 2003, a global enterprise built upon the core values of United, Networked, Innovative, Beyond, Efficient, Satisfied, and Technological.
Trading
Pharmaceutical APIs, intermediates, and Biopharma products with a major presence in European and American markets, backed by our own CDMO facilities.
Licensing
In-licensing and out-licensing of drug candidates and finished products, covering innovative drugs, generic drugs, and chemical intermediates.
Global Network
Business centers across Asia, Europe, North America, and Oceania, cultivating long-term partnerships with major multinational pharmaceutical corporations.
1100+Partners
3700+Projects
330+Supplier Audits
23+Years Experience
51%+Master's / PhD
Values
Every letter of UNIBEST stands for a principle we live by.
Satisfied
Efficient
Technological
Networked
Innovative
Beyond
United
History
Two decades of relentless growth.
2007
Founded Shanghai Unibest Biopharma, initiating a strategic upgrade to focus on independent technology R&D in the pharmaceutical sector.
2009
Invested in Shanghai Qinlong Chemical (CDMO base), completing the full industry chain layout and integrating R&D, production, and sales.
2012
Acquired a stake in Xi'an Caijing Opto-Electrical Science & Technology Co., Ltd., venturing into the field of pharmaceutical materials.
2013
Established Ningbo Advirtue Biomedical Technology Co., Ltd., focusing on early-stage biomedical projects.
2015
Invested in Guangzhou Taqing Environmental, supporting the green production transformation in the chemical and pharmaceutical industries.
2018
Invested in Shenzhen Aoqi Bio-Tech, developing a dual-track approach for improved new drugs and drug delivery systems.
2019
Focused on technological breakthroughs: Shanghai Unibest Biomedical for high-end intermediates, Zhejiang Tize Biomedical for AI drug design + continuous flow technology, Nanjing Daoyi Biomedical for large-molecule LNP delivery systems.
2022
Established SingaPharma Pte. Ltd. to build a platform for pharmaceutical import and licensing in the Asia-Pacific region.
2023
Established an Auckland business center in New Zealand, setting up a new overseas foothold for Asia-Pacific market expansion.
2024
Established business centers in Paris and New York, forming a dual-core structure in Europe and the U.S. to cover European market access and North American commercialization resources.
2025
Unibest's new global headquarters was unveiled, marking the beginning of a new chapter in the company's international expansion.
Team
The people driving Unibest's global vision.
Allan Ko
Chairman
- 25 years of experience in global chemical trade and biopharmaceutical investment
- Founded Unibest and made strategic equity investments in multiple biopharmaceutical companies
- Honorary Professor at the School of Pharmacy, Lanzhou University
- Department of Economics and Management, Zhejiang University of Technology
- CEIBS EMBA
- Tsinghua SEM · TechFuture (E-DBA)
John Ren
General Manager
- 21 years of experience in management, business operations, and portfolio listing
- Senior Manager of Pharmaceutical Project Operations at Roche
- Director of Technical Marketing, Fujifilm Wako Pharmaceutical
- Founder of WuXi Biologics Suzhou Base (CMAB Pharmaceuticals)
- Doctoral degree in Pharmaceutical Management from the University of Otago
- Master of Pharmaceutical Science, University of Auckland
Steven Xia
Vice President
- Graduated from Zhejiang University in 1997
- One of the three founders of Unibest
- Over 20 years of working experience in the pharmaceutical industry
- Has established cooperation with more than 20 globally renowned pharmaceutical companies
- Has successfully expanded the business from Pharma to Biopharma
Wayne Gong
Vice President
- Joined Unibest in 2009 and currently serves as one of the company's partners
- Over 16 years of hands-on experience in the pharmaceutical industry
- More than 8 years of business operations and team management at Fortune 500 companies
- Leads the CDMO business for pharmaceutical intermediates
- Master of Business Administration (MBA), Fudan University
What is ESG
Check what and how we do to build a better world.
Unibest believes everyone has the responsibility to take care of our beautiful planet. We consider Sustainable Development Goals (SDGs) everywhere within our reach.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →